Efficacy and safety of rt-PA intravenous thrombolysis in patients with wake-up stroke: A meta-analysis

BACKGROUND: : Recombinant tissue plasminogen activator (rt-PA) is one of the most effective therapies for patients with acute ischemic stroke. However, wake-up stroke (WUS) is typically excluded from intravenous thrombolytic therapy because of the unclear time of symptom onset. Therefore, we aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hongfa, Hu, Weihua, Zhang, Fang, Gu, Wei, Hong, Jiankun, Chen, Jianping, Huang, Ying, Pan, Huoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282081/
https://www.ncbi.nlm.nih.gov/pubmed/35363213
http://dx.doi.org/10.1097/MD.0000000000028914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282081/
https://www.ncbi.nlm.nih.gov/pubmed/35363213
http://dx.doi.org/10.1097/MD.0000000000028914

Ejemplares similares